Briefing

Featured article

Eli Lilly boosts sales forecast by $3bn as diabetes and weight loss drugs propel revenue

Also in this section

News in Numbers

Latest News

Latest Deals

Project Updates

08/27/2024 15:19:24
  • Home | Pharma casts a wide net to hook opportunities in metabolic disorders
  • Editor's letter
  • Contents
  • Mimotopes Company Insight
  • Mimotopes
  • Datwyler
  • BiomeBank Company Insight
  • Briefing
  • News in Numbers
  • Latest News
  • Latest Deals
  • Project Updates
  • Molnar-Institute Company Insight
  • Molnar-Institute
  • Allpack Group AG Company Insight
  • Science4Tech
  • ZETA
  • In Depth
  • Pharma casts a wide net to hook opportunities in metabolic disorders
  • Alzheimer’s: drug delivery and the blood brain barrier conundrum
  • Era of ADCs: Pharma companies innovate to stand out in a buzzing market
  • AbbVie’s Humira loss of exclusivity has been a missed opportunity for competitors
  • How NVIDIA grew with the healthcare market instead of pushing into it
  • Sponsored Supplements
  • Faravelli
  • Simtra BioPharma Solutions
  • Listings
  • Events
  • Excellence Awards
  • Excellence Awards 2024: TrialHub
  • Innovation Rankings
  • Buyer's Guides
  • Next issue
08/27/2024 00:00:00